Related Experiment Video

Updated: Feb 15, 2026

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
06:16

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments

Published on: May 9, 2019

8.1K

GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib

Theodore Lemuel Mathuram1, Lisa M Reece2, Kotturathu Mammen Cherian3

  • 1Department of Stem Cell and Tissue Engineering, Frontier Mediville (A Unit of Frontier Lifeline and Dr. K. M. Cherian Heart Foundation), Affiliated to University of Madras, Chennai, Tamil Nadu, India.

Drug Research
|February 2, 2018
PubMed

Insights

Glycogen synthase kinase-3 (GSK-3) inhibitors show promise in treating diseases like cancer and aiding regenerative medicine. However, their complex role, especially in cancer, requires careful consideration of potential side effects.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Glycogen synthase kinase-3 (GSK-3) inhibitors are increasingly explored for therapeutic applications.
  • Their roles in nervous system disorders, diabetes, regenerative medicine, and cancer are subjects of ongoing research.
  • Conflicting data exists regarding the precise impact of GSK-3 inhibitors in cancer treatment.

Purpose of the Study:

  • To review the evolution of GSK-3 inhibitors from research tools to potential drug candidates.
  • To highlight the specific roles of key GSK-3 inhibitors in cancer and regenerative medicine, with a focus on tideglusib.
  • To provide a concise overview of GSK-3's involvement in critical molecular pathways.

Main Methods:

  • Literature review of scientific publications on GSK-3 inhibitors.
  • Analysis of studies investigating GSK-3 inhibitors in cancer and regenerative medicine models.
  • Synthesis of information on GSK-3's molecular functions and pathway involvement.

Main Results:

  • GSK-3 inhibitors have demonstrated diverse therapeutic potential across multiple disease areas.
  • Tideglusib is identified as a key GSK-3 inhibitor with notable applications in cancer and regenerative medicine.
  • The dual role of GSK-3 inhibitors, acting as a 'double-edged sword,' is evident in their complex effects.

Conclusions:

  • GSK-3 inhibitors represent a significant advancement in molecular-targeted therapies.
  • Their application requires careful consideration due to potential off-target effects and controversial roles in certain diseases like cancer.
  • Further research is needed to fully elucidate and safely harness the therapeutic potential of GSK-3 inhibitors.

More Related Videos

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

934
Quantitative Analysis of Cell Edge Dynamics during Cell Spreading10:54

Quantitative Analysis of Cell Edge Dynamics during Cell Spreading

Published on: May 22, 2021

6.0K

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
15.0K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

4.5K
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH301:11

ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.6K
Double Resonance Techniques: Overview01:12

Double Resonance Techniques: Overview

Double resonance techniques in Nuclear Magnetic Resonance (NMR) spectroscopy involve the simultaneous application of two different frequencies or radiofrequency pulses to manipulate and observe two distinct nuclear spins. One important application of double resonance is spin decoupling, which selectively suppresses coupling with one type of nucleus while observing the NMR signal from another nucleus, simplifying the spectrum and enhancing resolution.
Spin decoupling is usually achieved by...
788
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
718